Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pierre Jouan Biotechnologies SA was a French biotechnology company specializing in the extraction and purification of bioactive proteins from dairy sources, particularly milk and whey. Founded in the early 2000s by researcher Pierre Jouan and colleagues from the French National Institute for Agricultural Research (INRA), the company developed proprietary methods for isolating Transforming Growth Factor beta (TGF-beta) in its activated form. These protein fractions were targeted for the treatment of inflammatory conditions, gastrointestinal disorders such as ulcers and gastritis, and tissue repair. The company's technology utilized advanced microfiltration and diafiltration processes to produce highly enriched protein powders for therapeutic and nutritional applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jouan Biotechnologies.